Beth Israel Deaconess Medical Center Inc - 02215 Boston, MA

Business Name: Beth Israel Deaconess Medical Center Inc
Categorized In: Hospitals
Address: 330 Brookline Avenue, Boston, MA 02215
Phone Number: (617) 667-2131
Contact Person: Paula Goodman Fraenkel
Website Address: bidmc.org
NAICS Code: 622110
SIC Code: 8062
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Branch
Annual Revenue ($): Unknown
Share This Business:
Similar Businesses: Decision Support - Boston, MA 02215
Beth Israel Deaconess Medical Center Inc - Boston, MA 02215
Beth Israel Deaconess - Boston, MA 02215
Beth Israel Deaconess Medical Center Inc - Boston, MA 02215
Arnold Pain Center - Boston, MA 02215
N E Deaconess Hospital - Boston, MA 02215
Deaconess Medical Center - Boston, MA 02215
Boston Medical Center - Boston, MA 02215
Brigham Womens Hospital - Boston, MA 02215
Comprehensive Epilepsy - Boston, MA 02215
Beth Israel Medical Center - Boston, MA 02215
Beth Israel Deaconess Medical Center Inc - Boston, MA 02215
Delbanco Thomas MD - Boston, MA 02215
Beth Israel Deaconess Medical Center Inc - Boston, MA 02215
Beth Israel Deaconess Bus Office - Boston, MA 02215
Beth Israel Deaconess Department Of Medicine - Boston, MA 02215
Beth Israel Deaconess Medical Center Inc - Boston, MA 02215
Boston Medical Center Corporation - Boston, MA 02215

Beth Israel Deaconess Medical Center Inc provides professional Hospitals from its branch at the coordinates .

The company offers B2C variables under the SIC code 8062 and NAICS code 622110, while making an annual revenue of Unknown and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 330 Brookline Avenue, Boston, Massachusetts 02215 or contacted through representative Paula Goodman Fraenkel at (617) 667-2131.

For frequently asked questions and further inquiries about professional Hospitals, get to know more about Beth Israel Deaconess Medical Center Inc through its company website at bidmc.org. Engage with this business on its social media platforms through on Twitter and on Facebook.